Congenital Hyperinsulinism Treatment Market Driven by Innovations in Surgery and Drug Therapies Congenital Hyperinsulinism (HI) is a condition where the pancreas produces excess insulin resulting in recurrent episodes of hypoglycemia in infants and children, leading to seizures or coma if not treated on time. Treatment of congenital HI requires controlling insulin levels to maintain normal blood glucose levels and prevent hypoglycemia.
The global congenital hyperinsulinism treatment...
0 Compartilhamentos
397 Visualizações
0 Anterior